The Metabolic Signature of Job Stress - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Metabolic Signature of Job Stress

  • November 17, 2026

  • 2 min

Share

Clinical Scorecard: The Metabolic Signature of Job Stress

At a Glance

CategoryDetail
ConditionJob stress and associated plasma metabolite differences
Key MechanismsStress-associated molecular features were mainly tentatively linked to lipids; glycerophospholipid metabolism was the only pathway significant after multiple-comparison correction.
Target Population143 male manufacturing workers in Fuzhou, China: 78 classified as experiencing job stress and 65 as not experiencing job stress.
Care SettingOccupational health research using fasting plasma metabolomics; the study does not establish a clinical diagnostic or treatment setting.

Key Highlights

  • A cross-sectional study identified 12 plasma molecular features associated with questionnaire-classified job stress after adjustment for demographic and lifestyle factors.
  • Eleven features were less abundant and one was more abundant in the stress group.
  • A model combining 10 features distinguished the groups with 85.6% accuracy during internal validation; it has not been tested in an independent cohort.
  • Metabolite identities were tentative, based on accurate-mass matching without tandem mass spectrometry or authentic reference standards.
  • The study was limited to men at one location, relied on self-reported stress, and could not establish causation.

Guideline-Based Recommendations

Diagnosis

    Management

    • The study did not evaluate management or treatment of job stress.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        The study included 143 male manufacturing workers in Fuzhou, China; it did not evaluate a treatment or prescribing population.

        No treatment or prescribing interventions were studied. The reported metabolite patterns are candidates for further investigation, not established clinical tests.

        Clinical Best Practices

        • Interpret the reported molecular features as tentative because assignments were based on accurate-mass matching within 10 ppm and were not confirmed by tandem mass spectrometry or authentic standards.
        • Do not treat the internally validated 85.6% classification accuracy as evidence of performance in other populations; independent-cohort testing was not reported.
        • Consider the study's cross-sectional design, single-location male population, and self-reported stress classification when interpreting its findings.

        Related Resources & Content

        Original Source(s)

        Related Content